O'Malley, Circuit Judge.
HEC Pharm Co., Ltd. and HEC Pharm USA Inc. (collectively, "HEC") appeal from a district court bench trial in which the court found that a patent assigned to Novartis Pharmaceuticals Corp. ("Novartis"), U.S. Patent No. 9,187,405 ("the '405 patent"), is not invalid and that HEC's Abbreviated New Drug Application ("ANDA") infringes...
Let's get started
Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.
- Updated daily.
- Uncompromising quality.
- Complete, Accurate, Current.